We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+3.41%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$1.76B
AUM Growth
-$218M
Cap. Flow
-$265M
Cap. Flow %
-15.02%
Top 10 Hldgs %
22.75%
Holding
203
New
31
Increased
55
Reduced
62
Closed
55

Top Buys

Rank Stock Value
1
RNG icon
RingCentral
RNG
+$36.8M
2
ACHC icon
Acadia Healthcare
ACHC
+$30.7M
3
BILL icon
BILL Holdings
BILL
+$20.8M
4
OMC icon
Omnicom Group
OMC
+$15.9M
5
EQX icon
Equinox Gold
EQX
+$14.9M

Top Sells

Rank Stock Value
1
DNB
Dun & Bradstreet
DNB
+$33.6M
2
SLB icon
SLB Ltd
SLB
+$23.7M
3
MTCH icon
Match Group
MTCH
+$22.9M
4
MUR icon
Murphy Oil
MUR
+$19.4M
5
LYFT icon
Lyft
LYFT
+$18.8M

Sector Composition

Rank Sector Weight
1 Technology 25.6%
2 Consumer Discretionary 17.8%
3 Healthcare 16.38%
4 Industrials 9.22%
5 Materials 9.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPN icon
1
Global Payments
GPN
$22.1B
$49.1M 2.79%
613,023
+109,057
+22% +$8.63M
XRAY icon
2
Dentsply Sirona
XRAY
$2.59B
$46.5M 2.64%
2,925,562
+448,656
+18% +$6.71M
VTRS icon
3
Viatris
VTRS
$20.1B
$41.5M 2.35%
4,643,175
-1,793,457
-28% -$15.2M
EGO icon
4
Eldorado Gold
EGO
$8.31B
$41.3M 2.35%
2,031,897
-230,284
-10% -$4.48M
RNG icon
5
RingCentral
RNG
$4.05B
$40.5M 2.3%
+1,427,359
New +$36.8M
CLVT icon
6
Clarivate
CLVT
$1.3B
$40.4M 2.29%
9,385,087
+904,791
+11% +$3.64M
CNXC icon
7
Concentrix
CNXC
$1.36B
$36.3M 2.06%
686,916
+152,652
+29% +$8.06M
ST icon
8
Sensata Technologies
ST
$6.65B
$35.9M 2.04%
1,193,567
-390,521
-25% -$9.58M
LYFT icon
9
Lyft
LYFT
$5.39B
$35.4M 2.01%
2,244,315
-1,343,238
-37% -$18.8M
AKAM icon
10
Akamai
AKAM
$16.8B
$34.1M 1.94%
427,924
-219,741
-34% -$17.1M
TFX icon
11
Teleflex
TFX
$5.85B
$33.7M 1.91%
284,385
-60,347
-18% -$7.61M
ACHC icon
12
Acadia Healthcare
ACHC
$3.17B
$31M 1.76%
1,367,600
+1,295,821
+1,805% +$30.7M
MTB icon
13
M&T Bank
MTB
$36.2B
$30.7M 1.74%
158,053
+73,388
+87% +$12.9M
SSYS icon
14
Stratasys
SSYS
$697M
$30.6M 1.74%
2,670,573
+204,375
+8% +$2.07M
BILL icon
15
BILL Holdings
BILL
$4.33B
$29.8M 1.69%
644,562
+470,351
+270% +$20.8M
AAP icon
16
Advance Auto Parts
AAP
$3.37B
$29.3M 1.66%
630,595
+29,700
+5% +$1.19M
PVH icon
17
PVH
PVH
$3.71B
$28.4M 1.61%
414,452
+103,882
+33% +$7.54M
SON icon
18
Sonoco
SON
$5.76B
$28.1M 1.6%
645,636
-156,559
-20% -$7M
TNC icon
19
Tennant Co
TNC
$1.5B
$27.2M 1.54%
350,464
+70,664
+25% +$5.22M
PYPL icon
20
PayPal
PYPL
$49.5B
$26.6M 1.51%
357,615
-73,875
-17% -$5.06M
PENN icon
21
PENN Entertainment
PENN
$2.74B
$26.2M 1.49%
1,468,911
-390,201
-21% -$6.12M
CART icon
22
Maplebear
CART
$9.92B
$25.5M 1.45%
563,191
+170,196
+43% +$7.4M
WBD icon
23
Warner Bros
WBD
$64.6B
$22.1M 1.25%
1,927,234
-1,326,889
-41% -$12.4M
M icon
24
Macy's
M
$6.15B
$21.9M 1.24%
1,875,225
+151,011
+9% +$1.75M
SNAP icon
25
Snap
SNAP
$7.32B
$21M 1.19%
2,414,663
+431,216
+22% +$3.58M

Similar funds

Invenomic Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, Invenomic Capital Management held 203 positions worth $1.76B, down 11% from $1.98B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Invenomic Capital Management withdrew a net $265M in Q2 2025, closing 55 positions and reducing 62 holdings. Its most notable exit was Dun & Bradstreet, an estimated $33.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Invenomic Capital Management opened a new position in RingCentral worth $40.5M.

  • Invenomic Capital Management's largest Q2 2025 buy was RingCentral: 1,427,359 shares worth $40.5M.
  • Invenomic Capital Management added most to Acadia Healthcare in Q2 2025, an estimated $30.7M increase.
  • Invenomic Capital Management's biggest Q2 2025 reduction was Match Group, cutting an estimated $22.9M.
  • Invenomic Capital Management fully exited Dun & Bradstreet in Q2 2025, selling an estimated $33.6M.
  • Invenomic Capital Management's ten largest holdings make up 23% of its $1.76B portfolio in Q2 2025.
  • Invenomic Capital Management opened 31 new positions and closed 55 in Q2 2025.
  • Invenomic Capital Management's portfolio value fell 11% quarter-over-quarter to $1.76B.

Based on Invenomic Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.